Abonneer je op onze nieuwsbrief om op de hoogte te blijven
Klik hier
  • BLS
  • Spotlight

Safety guide: chemical pharmaceutical industry

BLS Safety Guide: chemical-pharmaceutical industry


A guide written by Dr. Antonio Moffa, Dr. Claudia Beccaria and Lucrezia Giorgi of the Unit of Integrated Therapies in Otolaryngology at the University Polyclinic Campus Bio-Medical Foundation in Rome.

 

The manufacture of pharmaceutical products involves the use of numerous chemicals, obtained by fermentation, organic or biological synthesis, which can sometimes be used in very high concentrations and risk endangering the health or safety of operators.

 

 

The handling of chemical or biological substances used in drugs and reagents involves acute and chronic risks. The toxic effects, such as mutagenesis and neurotoxicity, are often irreversible and may persist over time. The most commonly used products include solvents, corrosive acids and caustic bases. It is essential to manage these risks to ensure the safety of operators and the public.

Granulating, mixing and wet coating operations can expose operators to high solvent vapours. During other steps such as distribution, drying and mixing, airborne particles may increase exposure. Thehandling and storage of these products pose risks of exposure through inhalation, ingestion or direct contact during plant breakdowns. These risks must be carefully managed to prevent harmful exposures and related diseases. Below are the risks related to the various work steps of toxic products and associated diseases. (see table)

 

 

Toxicity risks depend on the physical and chemical properties of the products and the routes of entry into the body. Workers in pharmaceutical industries may be exposed to chemicals through inhalation, skin contact, ingestion and eye projection. Common occupational diseases in the industry include osteomuscular, respiratory, ear problems, tumours and other diseases. Exposures to dust, gaseous compounds and solvent vapours can cause allergic reactions, respiratory disorders and cancers. The substances most frequently implicated as causes of occupational diseases include asbestos, hydrocarbon derivatives and other specific chemicals.

 

 

In pharmaceutical industries, risk prevention is based on a number of collective and individual measures. Collective measures include adequate infrastructure such as well-designed rooms, safe work plans and effective ventilation devices to capture pollutants. Automation of operations through remote-controlled and controlled systems reduces the risk of operator exposure. In addition, hygienic equipment such as safety showers and eye wash stations are essential, along with hygienic practices such as hand washing.

 

In order to protect operators from chemical hazards arising from pharmaceuticals, excipients, solvents and disinfectants, the use of personal protective equipment is required. These include:

- Hand protectors, protecting against chemicals, heat, frost and potential allergens.
- Eye and face protectors, protecting against splashes, drops, dusts and irritating gases.
- Body protectors, especially in case of exposure to corrosive substances.
- Respiratory devices, protecting against the harmful effects of gases, vapours, dusts, fibres, fumes and mists.

Furthermore, it is essential that operators receive training and detailed information on the risks associated with the products and materials used, so that they can adopt safe behaviour while working.

 

Recommended products:

 

 

 

Stay informed
Stay safe.

 

Gerelateerde artikelen

juni 3, 2025 Préventica Paris 2025

BLS è a Préventica Paris 2025 Parigi (Francia), 10-12 giugno  2025 BLS sarà presente all'evento dedicato alla salute, alla sicurezza e alla qualità della vita sul lavoro: Prévventica 2025, che si terrà a Parigi dal 10 al 12 di giugno. Vieni a trovarci. Siamo allo stand C53.   La fiera A ogni edizione, Préventica propone un'offerta […]

Link
april 21, 2018 New European Regulation (EU) 2016/425 on PPE

From April 21st 2018, the new EU Regulation 2016/425 has been in force, replacing the previous Directive 89/686/EEC and establishing the requirements for the design and manufacture of personal protective equipment (PPE).

Link
juni 12, 2025 Focus | BLS Zer0 33 WVT Ratio

BLS Zer0 33: alta traspirabilità I facciali filtranti a 3 lembi della serie BLS Zer0 Flat offrono un’elevata protezione unita a un eccezionale comfort respiratorio grazie alla loro elevata traspirabilità.   Quando si parla di dispositivi di protezione delle vie respiratorie, comfort e sicurezza devono procedere insieme. È questo l’obiettivo della BLS Zer0 33, un […]

Link

Abonneer op onze nieuwsbrief

Ontvang updates over onze evenementen, nieuws, catalogus en aankomende initiatieven.
Abonneren

Neem contact op

Laat uw bericht achter, wij antwoorden binnen 48 uur.

Vraag informatie aan

Download de gratis veiligheidsgids

Elke sector heeft de juiste bescherming nodig. Download onze gratis veiligheidsgids voor meer informatie.
Scarica
crossmenuchevron-downcross-circle